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Hemodialysis with high-calcium dialysate impairs cardiac relax- The changes in cardiac preload, blood pressure, heart
ation. rate, and blood chemistry that take place during a hemo-
Background. During hemodialysis (HD), serum ionized cal- dialysis (HD) session are an enormous stress to cardiac
cium is directly related to the dialysate calcium concentration.
function. Additionally, patients with end-stage renal dis-We have recently shown an acute induction of hypercalcemia
ease (ESRD) often have left ventricular (LV) hypertro-to impair left ventricular (LV) relaxation. In the current study
we sought to establish whether changes in serum Ca11 also phy and systolic as well as diastolic dysfunction [1–8].
affect LV function during HD. Together, this explains the high prevalence of cardiovas-
Methods. We echocardiographically examined the LV relax- cular instability during HD treatment.
ation and systolic function of 12 patients with end-stage renal
Studies on the effects of HD on LV systolic functiondisease before and after three HD treatments with dialysate
have yielded contradictory results [9–15], whereas sev-Ca11 concentrations of 1.25 mmol/liter (dCa111.25), 1.5 mmol/
eral studies have proved HD procedure to impair LVliter (dCa111.50), and 1.75 mmol/liter (dCa111.75), respec-
tively. Age- and sex-matched healthy controls were also exam- diastolic filling [13–16]. Cardiac preload has been shown
ined echocardiographically. to strongly affect the Doppler indices of LV filling [16,
Results. The LV posterior wall thickness and the interven- 17], but it is most likely not the only determinant of LV
tricular septum thickness, and the LV end-diastolic dimension
relaxation during HD treatment.and the end-systolic dimensions were significantly greater in
During HD, serum-ionized calcium varies directly withthe patients when compared with the controls, and the LV
fractional shortening, the ratio of peak early to peak late dia- the dialysate Ca11 concentration, and changes in serum
stolic velocities (E/Amax), and the isovolumic relaxation time calcium suppress or stimulate the secretion of parathy-
(IVRT) showed impairment of LV relaxation and systolic func- roid hormone (PTH) [18, 19]. Calcium has an essential
tion in the patients. Serum ionized calcium increased signifi- role in the contraction and relaxation of cardiac myocytecantly during the dCa111.5 HD (1.24 6 0.10 vs. 1.34 6 0.06
[20], and PTH affects the cardiac cytosolic calcium ho-mmol/liter, P 5 0.004) and dCa111.75 HD (1.19 6 0.10 vs.
meostasis [21, 22]. We have recently shown that the acute1.47 6 0.06 mmol/liter, P 5 0.002), and plasma intact parathy-
roid hormone decreased significantly during the dCa111.75 induction of hypercalcemia by calcium infusion impairs
HD (medians 8.2 vs. 2.7 pmol/liter, P 5 0.002). LV systolic LV relaxation [8]. This finding prompted us to study
function was not altered during any of the treatments. The whether corresponding changes in serum concentration
changes in E/Amax and IVRT suggested impairment of relax- of ionized calcium induced by HD affect LV relaxation.ation during all sessions, but only during the dCa111.75 HD
In this study, we echocardiographically examined thewas the impairment statistically significant (E/Amax 1.153 6
effect of different serum calcium concentrations on LV0.437 vs. 0.943 6 0.352, P , 0.05; IVRT 147 6 29 vs. 175 6
50 msecond, P , 0.05). relaxation and systolic function during HD treatment by
Conclusion. HD with high-calcium (dCa111.75 mmol/liter) performing three dialysis treatments, each with a differ-
dialysate impairs LV relaxation when compared with lower ent dialysate Ca11 concentration.calcium dialysate (dCa111.25 and dCa111.5 mmol/liter) treat-
ments.
METHODS
The study group consisted of 12 ESRD patients (10Key words: hypercalcemia, left ventricle, cardiac systolic function,
chronic renal failure. males, 2 females) undergoing regular HD three times a
week, four to five hours per session. The age of theReceived for publication June 16, 1998
patients ranged from 24 to 76 (median 56) years, andand in revised form September 28, 1998
Accepted for publication September 28, 1998 the patients had been in HD treatment from 1 to 41
(median 13) months. The causes of ESRD were diabetic 1999 by the International Society of Nephrology
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nephropathy (N 5 4), chronic glomerulonephritis tum and the posterior wall was measured at the onset
of the electrocardiographic Q wave. The LV end-systolic(N 5 3), hypertensive nephrosclerosis (N 5 2), second-
ary amyloidosis (N 5 1), polycystic (N 5 1), and hypo- dimension (LVESD) was measured at the time of the
smallest LV diameter. LV fractional shortening (FS) wasplastic (N 5 1) kidney diseases. Two patients had conges-
tive heart disease, eight were hypertensive, and four had defined as (LVEDD 2 LVESD) 3 100/LVEDD. The
mitral inflow velocity was measured in the apical four-myocardial infarction in their medical histories. An elec-
trocardiogram taken before the study proved all patients chamber view. The sample volume was placed at the tips
of the mitral valve leaflets, whereby the Doppler beamto be in sinus rhythm. Eight patients were receiving b
blockers, three calcium antagonists, three angiotensin- direction was aligned parallel to the expected direction
of the ventricular inflow. The following indices wereconverting enzyme inhibitors, five nitrate agents, and
four took diuretics. All patients were taking vitamin B measured: peak early diastolic velocity (Emax), peak late
diastolic velocity (Amax), and the E/Amax ratio. The iso-and C substitutions, seven calcium-containing phosphate
binders, and five took a vitamin D analogue. Six patients volumic relaxation time (IVRT) was measured as the
time from closure of the aortic valve to the onset ofwere treated with erythropoietin. All patients continued
their medication unchanged throughout the study. mitral valve opening and the deceleration time (DT) as
the time from the peak to the end of the E wave.During the study period of three weeks, all patients
underwent three study HD sessions on the same day of The control group consisted of age- and sex-matched
healthy subjects who were also echocardiographicallythe week two days after the preceding normal dialysis.
During these three study days, different dialysate cal- examined. All patients gave informed consent, and the
study was approved by the Ethics Committee of Tam-cium concentrations were used as follows: On the first
day, the dialysate Ca11 concentration was 1.25 mmol/ pere University Hospital.
liter (dCa111.25); on the second day, 1.75 mmol/liter
Statistical methods(dCa111.75); and on the third day, 1.50 mmol/liter
(dCa111.50). Except for the concentration of calcium, The means and standard deviations of all variables
were calculated. The Wilcoxon signed-ranks test forthe compositions of the three dialysates were compara-
ble. On the study days, the dialysate flow was 500 ml/ paired samples, the Mann–Whitney U-test, a simple re-
gression, and a multiple regression analysis with forwardmin, and the average blood flow was 280 6 50 ml/min.
The other dialyses between the study days were carried variable selection were used to determine statistical sig-
nificance, and P values of less than 0.05 were consideredout according to patients’ routine dialysis program, the
dialysate Ca11 concentration being 1.50 mmol/liter for significant. The Statgraphicsw (version 7.0) statistical
package was used (Manugistics, Inc., Rockville, MD,11 patients and 1.25 mmol/liter for 1 patient.
Before and immediately after the three HD sessions, USA).
each patient was studied by cardiac echocardiography.
At the beginning and the end of HD, blood pressure
RESULTS
was measured and blood samples were collected for the
Clinical findingsmeasurement of ionized calcium, phosphate, intact PTH,
sodium, potassium, creatinine, urea, hemoglobin, mag- The predialysis and postdialysis values of systolic, dia-
stolic, and mean arterial blood pressures, heart rate, bodynesium, pH, and bicarbonate. The concentration of se-
rum-ionized calcium was measured with a Radiometer weight, and total ultrafiltration (UF) are shown in Table
1. Both the predialysis and the postdialysis values andICA-1 Analyzer (Radiometer A/S, Copenhagen, Den-
mark). The concentration of intact PTH in the plasma the dialysis-induced changes of all these parameters were
comparable between the different dialysis sessions. Dur-was determined by two-site immunoradiometry (N-tactt
PTH IRMA; Incstar Corp., Stillwater, MN, USA). Other ing the dCa111.75 HD, systolic and mean arterial blood
pressure tended to rise, but the changes were not statisti-laboratory analyses were made by routine automatic
methods. cally significant.
All echocardiographic examinations were made by
Laboratory findingsone investigator (V.K.V.) in a blinded fashion with the
investigator not being aware of the dialysate Ca11 con- The laboratory values measured before and after the
three different HD procedures are shown in Table 2.centration used. A System FiVe 1.3 ultrasound system
(Vingmed Sound AIS, Horten, Norway) equipped with Mean serum-ionized calcium was within the normal
range at the beginning of each dialysis session, and therea 2.5 MHz transducer was used. Standard M-mode mea-
surements of the LV were obtained from the parasternal were no differences in the predialysis values of serum-
ionized calcium or plasma intact PTH between the ses-long-axis view, the cursor being placed immediately be-
low the mitral valve tips. The LV end-diastolic dimension sions. During the dCa111.25 dialysis, serum-ionized cal-
cium tended to decrease (1.20 6 0.11 vs. 1.17 6 0.08(LVEDD) and the thickness of the interventricular sep-
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Table 1. Clinical data on the 12 patients before (pre) and after (post) the three dialysis procedures
Dialysate Ca11 Dialysate Ca11 Dialysate Ca11
1.25 mmol/liter 1.5 mmol/liter 1.75 mmol/liter
pre post pre post pre post
Systolic BP mm Hg 151618 151 627 150 631 157 620 151 623 164 631
Diastolic BP mm Hg 8768 84 613 90 613 89 612 88 615 88 616
Mean arterial BP mm Hg 119611 118 618 121 621 123 616 119 617 126 621
Heart rate beats/min 71612 77616a 71610 79612a 73615 79617a
Body weight kg 85.0618.1 82.4617.1a 83.4618.7 81.5617.9a 84.0617.6 82.7617.8a
Total ultrafiltration ml 258061350 2120 62220 2160 62190
a Before vs. after hemodialysis, P , 0.05
Table 2. Pre- and postdialysis laboratory data on the three hemodialysis procedures in 12 hemodialysis patients
Dialysate Ca11 Dialysate Ca11 Dialysate Ca11
1.25 mmol/liter 1.5 mmol/liter 1.75 mmol/liter
Laboratory values and
the normal ranges pre post pre post pre post
Serum ionized calcium mmol/liter 1.2060.11 1.17 60.08 1.24 60.10 1.34 60.06a,b 1.1960.10 1.4760.06a,b,c
Plasma phosphate mmol/liter 1.9860.56 1.01 60.30a 2.1260.71 1.10 60.35a 1.9560.75 1.0860.36a
Plasma intact PTH pmol/liter 5.0 (median) 7.2 (median) 8.4 (median) 4.8 (median)b 8.2 (median) 2.7 (median)a,b,c
Plasma magnesium mmol/liter 0.9760.11 0.85 60.06a 0.9760.15 0.84 60.08a 0.9660.13 0.8460.06a
Blood hemoglobin g/liter 11368 119 614a 112614 119 613a 113612 118615a
Plasma sodium mmol/liter 14263 143 62 142 64 143 61 142 63 14361
Plasma potassium mmol/liter 5.060.7 3.6 60.4a 4.760.7 3.8 60.4a 4.760.6 3.760.3a
Plasma chloride mmol/liter 10264 99 62a 10265 100 62 102 65 10062
Plasma creatinine lmol/liter 7766310 348 6160a 7556293 346 6144a 7376288 3356141a
Serum urea mmol/liter 21.964.2 8.0 62.7a 20.065.0 7.5 62.4a 20.063.5 7.061.7a
pH 7.3760.02 7.44 60.05a 7.3660.04 7.45 60.04a 7.3860.04 7.4560.06a
HCO3 mmol/liter 22.562.3 28.5 61.2a 23.262.2 28.8 61.1a 23.062.5 28.361.0a
Reference values are: serum ionized calcium (1.15–1.30) mmol/liter), plasma phosphate (0.80–1.40 mmol/liter), plasma intact PTH (1.0–6.8 pmol/liter), plasma
magnesium (0.75–1.00 mmol/liter), blood hemoglobin (130–180 g/liter), plasma sodium (135–146 mmol/liter), plasma potassium (3.3–4.8 mmol/liter), plasma chloride
(96–111 mmol/liter), plasma creatinine (,115 mmol/liter), serum urea (3.0–8.5 mmol/liter), pH (7.35–7.44), HCO3 (22.0–27.0 mmol/liter).
a Predialysis vs. postdialysis, P , 0.05
b The post-dialysis value is significantly (P , 0.05) different from that in the dCa11 1.25 hemodialysis
c The post-dialysis value is significantly (P , 0.05) different from that in the dCa11 1.5 hemodialysis
mmol/liter, NS). During the dCa111.5 dialysis, serum- carbonate, pH, serum urea, and blood hemoglobin were
equal in the three dialysis sessions, as shown in Table 2.ionized calcium increased (1.24 6 0.10 vs. 1.34 6 0.06
mmol/liter, P 5 0.004), and the postdialysis serum value
Echocardiographic findingswas significantly (P 5 0.003) higher than after the
dCa111.25 dialysis. The dCa111.75 dialysis resulted in The Doppler and M-mode echocardiography data on
the patient group, measured before the dCa111.25 HD,a marked increase in serum-ionized calcium (1.19 6 0.10
vs. 1.47 6 0.06 mmol/liter, P 5 0.002), and the postdial- were compared with those on the control group (Table
3). The patient group had significantly thicker LV poste-ysis mean serum-ionized calcium was significantly higher
than after the dCa111.25 or dCa111.5 dialyses (P 5 rior wall (11.3 6 1.5 vs. 8.0 6 1.5 mm, P , 0.01) and
interventricular septum (13.4 6 2.1 vs. 8.9 6 1.5 mm,0.002 and P 5 0.003, respectively). At the beginning of
the study, the concentration of plasma intact PTH ranged P , 0.01) than the control group. LVESD (40.4 6 4.1
vs. 29.7 6 4.0 mm, P , 0.01) and LVEDD (58.4 6 8.6from 1.6 to 42.2 (median 5.0) pmol/liter; only three pa-
tients had notably high plasma PTH values (higher than vs. 51.9 6 3.3 mm, P , 0.05) were greater, and FS was
smaller (31 6 8 vs. 43 6 5%, P , 0.01) in the patients.three times the upper limit of the reference range). The
change in plasma PTH during the dCa111.25 HD (medi- Emax (0.773 6 0.172 vs. 0.610 6 0.103 m/second, P ,
0.05), Amax (0.669 6 0.235 vs. 0.430 6 0.072 m/second,ans 5.0 vs. 7.2 pmol/liter, NS) or the dCa111.5 HD (medi-
ans 8.4 vs. 4.8 pmol/liter, NS) was not significant, whereas P , 0.01), and IVRT (125 6 26 vs. 78 6 16 msecond,
P , 0.01) were greater, and E/Amax was slightly (1.278 6during the dCa111.75 HD, it decreased (medians 8.2 vs.
2.7 pmol/liter, P 5 0.002). Both the predialysis values 0.514 vs. 1.448 6 0.329, P 5 0.25) smaller in patients
than in controls.and the dialysis-induced changes in plasma phosphate,
magnesium, sodium, potassium, chloride, creatinine, bi- There was a slight decrease in Emax during all dialysis
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Table 3. M-mode and Doppler echocardiography data on the control subjects and patients, measured before (pre) and after (post) the
three dialysis treatments
Dialysate Ca11 Dialysate Ca11 Dialysate Ca11
1.25 mmol/liter 1.5 mmol/liter 1.75 mmol/liter
Controls P pre post pre post pre post
Emax m/second 0.61060.103 0.05 0.77360.172 0.64860.238 0.84560.09 0.66960.202a 0.79560.178 0.68860.187
Amax m/second 0.43060.072 ,0.01 0.66960.235 0.65860.282 0.71260.236 0.69160.303 0.73360.209 0.77560.263
E/Amax 1.44860.329 0.25 1.27860.514 1.11860.702 1.32560.616 1.08160.453 1.15360.437 0.94360.352a,b
IVRT msecond 78616 ,0.01 125626d 141633 147621 144629 147629 175650a,b,c
DT msecond 181632 0.38 179659 210679 174674 187663 176648 210691
LVEDD mm 51.963.3 0.02 58.468.6 54.9 69.6a 56.467.7 54.268.4 55.468.5 53.169.0
LVESD mm 29.764.0 ,0.01 40.469.8 40.168.0 42.169.5 36.8613.3 38.0611.8 38.4610.9
FS % 4365 ,0.01 3168 2969 2669 2766 33612 29610
PWT mm 8.061.5 ,0.01 11.361.5 11.161.7 11.761.4 11.562.2 11.761.9 12.862.2
IVST mm 8.961.5 ,0.01 13.462.1 14.062.7 13.661.5 13.462.0 13.562.4 13.761.5
LA mm 34.862.2 ,0.01 44.466.1 41.0 67.3a 43.066.7 39.665.2 45.166.7 42.865.7
AO mm 33.764.4 0.16 35.962.3 35.762.5 35.962.6 35.862.4 36.962.9 36.762.4
LA/AO 1.060.1 ,0.01 1.260.2 1.260.2 1.260.1 1.160.1 1.260.2 1.260.2
Abbreviations are: Emax, peak early diastolic velocity; Amax, peak late diastolic velocity; E/Amax, Emax/Amax ratio; IVRT, isovolumic relaxation time; DT,
deceleration time; LVEDD, left ventricle end diastolic dimension; LVESD, left ventricle end systolic dimension; FS, fractional shortening; PWT, posterior wall
thickness; IVST, interventricular septal thickness; LA, left atrium dimension; AO, aortic root dimension; LA/AO, LA/AO ratio.
P Values denote controls vs. patients (the predialysis values of dCa11 1.25 hemodialysis).
a Before vs. after hemodialysis, P , 0.05
b Postdialysis value is significantly (P , 0.05) different from that in the dCa11 1.25 hemodialysis
c Postdialysis value is significantly (P , 0.05) different from that in the dCa11 1.5 hemodialysis
d Predialysis value is significantly (P , 0.05) different from that in the dCa11 1.5 and dCa11 1.75 hemodialysis
treatments, but Amax remained unchanged. E/Amax de- ionized calcium and Emax (r 5 20.30, P , 0.05), E/Amax
(r 5 20.25, P , 0.05), and IVRT (r 5 0.25, P , 0.05).creased during HD in each session, suggesting impair-
ment of LV relaxation, but only during HD with the Plasma PTH did not correlate with any of the indices
dCa111.75 dialysate was the impairment statistically sig- of pulsed Doppler or M-mode echocardiography. In a
nificant. The predialysis values of E/Amax were compara- multiple regression analysis in which the total UF, the
ble between the three different procedures, but after the predialysis values of E/Amax, IVRT, FS, and LVEDD,
dCa111.75 dialysis, E/Amax was slightly smaller than after and the changes in serum-ionized calcium, heart rate,
the dCa111.5 dialysis (P 5 0.07) and was significantly and systolic and mean arterial blood pressure were inde-
smaller than after the dCa111.25 dialysis (P , 0.05). pendent variables, the change in serum Ca11 was the
Similarly, the dCa111.75 HD was the only procedure only variable correlating independently with the change
during which IVRT increased significantly (147 6 28 vs. in E/Amax (r 5 20.38, P , 0.05).
175 6 49 msecond, P , 0.05). Predialysis IVRT in the
dCa111.75 dialysis was greater than that with dCa111.25
DISCUSSIONdialysis but was comparable to that in the dCa111.5
We have previously shown that an acute rise in serum-dialysis. After the treatment, IVRT in the dCa111.75
ionized calcium concentration induced by calcium infu-dialysis was significantly greater than that in both the
sion impairs LV relaxation [8]. This study confirms thatdCa111.25 and dCa111.5 dialyses. Also, DT tended to
the changes in serum calcium concentration induced byincrease during each dialysis treatment, and the predial-
HD also have an effect on cardiac relaxation. The termysis and postdialysis values were comparable between
LV relaxation here comprises the energy- and calcium-the three procedures.
Left ventricular end-diastolic dimension and left atrium dependent phase of early ventricular filling, and the term
diastolic function merely represents the late phase of LVdimension (LA) decreased during all dialysis treatments,
the changes being significant in the dCa111.25 dialysis. filling affected by the restrictive processes [23].
Left ventricular systolic function was poorer and LVFS, interventricular septum thickness, or posterior wall
thickness did not change during any of the three HD wall thicknesses and dimensions greater in our patients
with ESRD than in healthy control subjects, which is insessions. All the indices of LV dimensions, wall thick-
nesses, and systolic function were comparable between agreement with previous reports [1–4, 6–8]. Our finding
of a slight impairment of LV relaxation in ESRD patientsthe three procedures both before and after treatment.
When the Doppler indices of LV relaxation were com- is also supported by other studies [4, 5, 7].
None of the three dialysis treatments with a differentpared with serum calcium levels before and after all three
sessions, there were weak correlations between serum- concentration of dialysate calcium induced changes in
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LV systolic function. This finding is compatible with Emax is known to be reduced along with an increase in
cardiac afterload [24]. Some researchers have reportedthose in previous studies [13, 15], which showed HD
treatment with a rise in serum calcium concentration both systolic and mean arterial blood pressure to in-
crease during high-calcium dialysis [25, 26], whereasto have no effect on LV systolic function. It has been
proposed that an HD procedure without fluid removal other studies have shown blood pressure to remain stable
during high-calcium HD [13, 15, 16] or acute inductionimproves LV systolic function if serum Ca11 increases
[10] or if, in addition to this, the plasma potassium con- of hypercalcemia [8]. In this study, systolic and mean
arterial blood pressure tended to rise during thecentration decreases [11]. In this study, we found no
change in LV systolic function in spite of the alteration dCa111.75 HD, but the changes did not reach statistical
significance during any session. LV relaxation is alsoin the serum concentrations of the electrolytes. Our pre-
vious study demonstrated that LV systolic function is affected by changes in heart rate [27] and cardiac preload
[14, 16, 17]. However, in our study, the predialysis andnot altered, although the serum-ionized calcium concen-
tration rises acutely [8]. Moreover, LV systolic function postdialysis values and the dialysis-induced changes in
systolic and mean arterial blood pressures, heart rate,has been shown to be independent of acute changes in
cardiac preload [17]. It therefore seems conceivable that mean body weight, and the total UF were comparable
between the three HD procedures. In a multiple regres-an HD procedure or acute changes in serum calcium
concentration do not have any significant effect on LV sion analysis containing the previously mentioned vari-
ables, serum-ionized calcium and the predialysis valuessystolic function.
During HD, the cardiac preload decreases consider- of E/Amax, IVRT, FS, and LVEDD, the dialysis-induced
change in E/Amax correlated independently only with se-ably as a result of fluid removal. Reduced preload has
been shown to reduce LVEDD, Emax, and E/Amax, while rum Ca11. Similarly, there were no differences in the
predialysis or postdialysis concentration of plasma phos-having no effect on Amax [14, 16, 17]. During the interval
between the HD sessions, the fluid retention, in turn, phate, magnesium, sodium, potassium, chloride, creati-
nine, pH, bicarbonate, serum urea, or blood hemoglobinexpands the circulating blood volume and thus increases
cardiac preload, resulting in a “pseudonormalization” of between the different sessions. Thus, the impairment of
LV relaxation during only the dCa111.75 dialysis cannotDoppler indices of LV inflow. As a matter of fact, several
studies have demonstrated a deterioration in LV dia- be explained by the changes in these variables.
During HD, serum-ionized calcium is directly relatedstolic indices during HD, but in all of these studies, the
serum concentration of calcium increased significantly to the dialysate calcium concentration, and changes in
Ca11 in turn induce a suppression or stimulation of para-during dialysis [13, 15, 16]. Therefore, although the ad-
verse effects of reduced preload on LV diastolic indices thyroid function [18, 19]. This makes it difficult to sepa-
rate the distinct effects of serum calcium and PTH onduring HD treatment are obvious, it has hitherto been
impossible to distinguish whether the changes in serum cardiac function during HD. Myocardial contraction and
relaxation are highly dependent on cytosolic calcium ho-calcium concentration have a separate effect on LV re-
laxation properties during an HD procedure. meostasis [20], and PTH has been shown to affect this
homeostasis [22]. Several studies have shown secondaryThere was a trend toward impairment of LV relaxation
(a decrease in E/Amax and an increase in DT and IVRT) hyperparathyroidism to be at least partly responsible
for the high prevalence of cardiac dysfunction and LVduring all treatments. However, E/Amax and IVRT
changed significantly only during the dCa111.75 dialysis, hypertrophy in patients with chronic renal failure [2, 6,
7, 28, 29]. Nevertheless, in this study, plasma PTH didthat is, when serum-ionized calcium increased signifi-
cantly. This finding goes well with that of our recent not correlate with any echocardiographic indices of LV
structure or function, whereas serum-ionized calciumstudy, which showed induction of acute hypercalcemia
to impair LV relaxation [8]. All of this may indicate correlated inversely with Emax and E/Amax and positively
with IVRT. A corresponding relationship between LVthat although the Doppler indices of LV inflow decrease
during HD treatment as a reflection of reduced cardiac relaxation and an acute change in serum-ionized calcium,
but not plasma PTH, was found in our previous study [8].preload, a significant deterioration in LV relaxation dur-
ing an HD procedure takes place only if there is a simul- Thus, although the long-term adverse effects of chronic
renal failure on cardiac structure and function may betaneous and marked increase in serum-ionized calcium
concentration. The impairment of LV relaxation during at least partly due to chronic excess of PTH, the acute
changes in LV relaxation that occur, for example, duringthe dCa111.75 HD did not induce any notable clinical
symptoms in our patients. However, the predialysis echo- HD treatment, may be predominantly due to changes in
serum-ionized calcium.cardiographic indices showed our patients to have only
mild LV dysfunction at the baseline, and it may be that In conclusion, we found that in patients with ESRD,
HD with high-calcium dialysate (dCa111.75 mmol/liter)the risk of clinical consequences is greater in ESRD
patients with more compromised cardiac function. impairs LV relaxation when compared with lower cal-
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